openPR Logo
Press release

Cancer Immunotherapy Market Growth: Trends, Innovations, and Forecast to 2030

Cancer Immunotherapy Market

Cancer Immunotherapy Market

The Global Cancer Immunotherapy Market is undergoing significant growth, driven by advancements in immunological research, rising cancer prevalence, and increased investment in innovative treatments. The market was valued at USD 118.12 Bn. in 2023 and is projected to grow at a robust CAGR of 9% from 2024 to 2030, reaching nearly USD 215.93 Bn. by 2030. This press release provides a detailed analysis of growth opportunities, consolidation activities, and recent developments across major regions, including Vietnam, Thailand, Japan, China, South Korea, Singapore, the US, and Europe.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž @https://www.maximizemarketresearch.com/request-sample/3333/

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ

Vietnam is witnessing an increasing demand for cancer immunotherapy solutions due to the rising prevalence of cancer. Partnerships between global companies such as ๐‘๐จ๐œ๐ก๐ž and local healthcare providers have enabled the introduction of advanced immunotherapy treatments. Vietnam's commitment to improving healthcare infrastructure further bolsters market growth.

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐

Thailand's cancer immunotherapy market is growing due to a focus on personalized medicine and advancements in immunotherapy drugs. Recent collaborations between ๐๐ซ๐ข๐ฌ๐ญ๐จ๐ฅ-๐Œ๐ฒ๐ž๐ซ๐ฌ ๐’๐ช๐ฎ๐ข๐›๐› and Thai oncology centers have paved the way for enhanced access to checkpoint inhibitors. The government's support for clinical trials adds to the market potential

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

Japan remains at the forefront of cancer immunotherapy innovation, driven by its strong pharmaceutical sector. Companies like ๐“๐š๐ค๐ž๐๐š ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ and ๐€๐ฌ๐ญ๐ž๐ฅ๐ฅ๐š๐ฌ ๐๐ก๐š๐ซ๐ฆ๐š are expanding their immunotherapy portfolios through strategic mergers and acquisitions. The country's focus on R&D for CAR-T cell therapy has significantly contributed to market consolidation.

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‚๐ก๐ข๐ง๐š

China's cancer immunotherapy market is witnessing rapid growth due to large-scale investments in biotechnology. Companies like ๐๐ž๐ข๐†๐ž๐ง๐ž and ๐ˆ๐ง๐ง๐จ๐ฏ๐ž๐ง๐ญ ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ are leading the charge with groundbreaking immunotherapy drugs. The Chinese government's policies promoting healthcare innovation and collaborations with international firms have further accelerated progress.

๐”๐ง๐ฅ๐จ๐œ๐ค ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ž๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฏ๐ข๐š ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/3333/

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š

South Korea's cancer immunotherapy market is characterized by advancements in precision medicine and biosimilar development. Companies like ๐‚๐ž๐ฅ๐ฅ๐ญ๐ซ๐ข๐จ๐ง and ๐’๐š๐ฆ๐ฌ๐ฎ๐ง๐  ๐๐ข๐จ๐ž๐ฉ๐ข๐ฌ are investing heavily in immunotherapy research. Collaborations with academic institutions and global biotech firms are driving innovation in the country.

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž

Singapore's strong emphasis on biomedical research has positioned it as a hub for cancer immunotherapy. Leading companies like ๐๐จ๐ฏ๐š๐ซ๐ญ๐ข๐ฌ and ๐Œ๐ž๐ซ๐œ๐ค & ๐‚๐จ. have established regional headquarters in Singapore, facilitating access to innovative immunotherapy treatments. The government's support for clinical trials further enhances market potential.

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ

The United States leads the global cancer immunotherapy market, with significant contributions from companies like ๐Œ๐ž๐ซ๐œ๐ค & ๐‚๐จ., ๐๐Ÿ๐ข๐ณ๐ž๐ซ, and ๐€๐ฆ๐ ๐ž๐ง. The introduction of groundbreaking therapies such as Keytruda and Opdivo has revolutionized cancer treatment. Recent acquisitions, including Pfizer's collaboration with BioNTech, underscore the country's focus on immunotherapy innovations.

๐‚๐š๐ง๐œ๐ž๐ซ ๐ˆ๐ฆ๐ฆ๐ฎ๐ง๐จ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Europe's cancer immunotherapy market is thriving due to strong R&D investments and a robust regulatory framework. Key players like ๐€๐ฌ๐ญ๐ซ๐š๐™๐ž๐ง๐ž๐œ๐š, ๐’๐š๐ง๐จ๐Ÿ๐ข, and ๐†๐ฅ๐š๐ฑ๐จ๐’๐ฆ๐ข๐ญ๐ก๐Š๐ฅ๐ข๐ง๐ž (๐†๐’๐Š) are driving market growth through strategic partnerships and acquisitions. EU-funded research projects focused on immunotherapy solutions are further propelling market expansion.

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ :https://www.maximizemarketresearch.com/request-sample/3333/

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐›๐ฒ ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ

Monoclonal Antibodies
Cytokines
Others

In 2023, monoclonal antibodies held a 42% market share, dominating the industry. They are mostly protective against cancer cells and can replicate, improve, and restore the immune system's response. Numerous malignancies, including brain, lung, breast, and lymphoma, are treated with them. Based on the proteins on the cell surface of cancer cells and those of healthy cells, they are made to recognize cancer cells and trigger a specific immune response.

๐›๐ฒ ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง

Lung Cancer
Breast Cancer
Melanoma
Prostate Cancer
Others

In 2023, lung cancer accounted for 44% of the market. Cancer cases are rising as a result of the advent of dangerous items like e-cigarettes. Lung cancer is the most common cancer globally, and awareness campaigns for treatment are growing. These elements are propelling the market segment's expansion.

๐›๐ฒ ๐„๐ง๐-๐”๐ฌ๐ž

Hospitals
Cancer Research Centers

In 2023, the Hospital Segment held a 60% market share, dominating the industry. The reasons propelling the segment's market expansion are the widespread use of cancer immunotherapy in hospitals and increased patient preference for hospitals.Over the course of the projected period, the Cancer Research Center is anticipated to expand at a CAGR of 4%. Throughout the projection period, the segment's expansion is anticipated to be driven by rising government investment and research and development.

๐†๐ž๐ญ ๐š ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:https://www.maximizemarketresearch.com/market-report/global-cancer-immunotherapy-market/3333/

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

1. Merck
2. Bayer AG
3. ELI Lilly and Company
4. Novartis
5. Pfizer
6. Janssen Global Service
7. Jhonson and Jhonson
8. Amgen
9. AstraZeneca
10.Hoffmann-La Roche Ltd.
11.Bristol-Mayers Squibb
12.Squibb Company
13.Sun Pharmaceutical Industries Ltd
14.Fresenius Kabi AG
15.Dr. Reddy's Laboratories Ltd.
16.Bausch Health
17.LUPIN
18.Teva Pharmaceutical Industries Ltd
19.Mylan N.V.
20.Hikma Pharmaceutical Plc.
21.Apotex Inc.
22.Immunomedics Inc.
23.Amneal Pharmaceutical Inc.
24.Aspen Holdings

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Floriculture Market https://www.maximizemarketresearch.com/market-report/global-floriculture-market/23982/

โ™ฆ Global Washing Machine Market https://www.maximizemarketresearch.com/market-report/washing-machine-market/14800/

โ™ฆ Fruit Fillings Market https://www.maximizemarketresearch.com/market-report/fruit-fillings-market/198740/

โ™ฆ Diamond Core Drilling Market https://www.maximizemarketresearch.com/market-report/diamond-core-drilling-market/199099/

โ™ฆ Global Frozen Bakery Market https://www.maximizemarketresearch.com/market-report/global-frozen-bakery-market/23735/

โ™ฆ Global Lemon Extract Market https://www.maximizemarketresearch.com/market-report/global-lemon-extract-market/27793/

โ™ฆ Global Optical Sorter Market https://www.maximizemarketresearch.com/market-report/global-optical-sorter-market/73696/

โ™ฆ Endoscopic Spinal Surgery Market https://www.maximizemarketresearch.com/market-report/global-endoscopic-spinal-surgery-market/80247/

โ™ฆ Global Voice over Internet Protocol (VoIP) Market https://www.maximizemarketresearch.com/market-report/global-voice-over-internet-protocol-voip-market/55029/

โ™ฆ Global Frozen Bakery Market https://www.maximizemarketresearch.com/market-report/global-frozen-bakery-market/23735/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Immunotherapy Market Growth: Trends, Innovations, and Forecast to 2030 here

News-ID: 3810573 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
Courier Services Market Set to Surge to USD 712 Billion by 2032 with a 5.8% CAGR
The Courier Services Market size was valued at USD 453.56 Billion in 2024 and the total Courier Services revenue is expected to grow at a CAGR of 5.8% from 2025 to 2032, reaching nearly USD 712.07 Billion. Courier Services Market Overview The global Courier Services Market has experienced significant growth, driven by the rising adoption of e-commerce, growing Internet penetration, and changing consumer lifestyles. Courier services provide quick, door-to-door delivery solutions forโ€ฆ
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market Set to Triple by 2030 with a Robust 15.58% CAGR
WealthTech Solutions Market was valued at USD 6.47 Billion in 2023, and it is expected to reach USD 17.83 Billion by 2030, exhibiting a CAGR of 15.58% during the forecast period (2024-2030). WealthTech Solutions Market Overview The global WealthTech Solutions Market is undergoing a transformative phase, driven by changing customer preferences, digital innovation, and evolving financial landscapes. WealthTech solutions provide digital tools and platforms that enhance operational efficiency for financial advisors, wealthโ€ฆ
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR Growth
Rapid Test Market Projected to Reach USD 80.07 Billion by 2032 with 8.81% CAGR G โ€ฆ
Global Rapid Test Market size was valued at USD 40.75 Bn. in 2024 and the total Rapid Test Market is expected to grow by 8.81% from 2025 to 2032, reaching nearly USD 80.07 Bn. Rapid Test Market Overview The global Rapid Test Market is witnessing significant growth, driven by the increasing demand for fast, accessible diagnostic solutions across healthcare settings and home-care applications. Rapid tests are designed to detect the presence ofโ€ฆ
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAGR Growth
Agarwood Oil Market Set to Approach USD 497 Million by 2032, Driven by 5.42% CAG โ€ฆ
Global Agarwood Oil Market size is expected to reach nearly US$ 496.84 Mn by 2032 with the CAGR of 5.42% during the forecast period. Agarwood Oil Market Overview Agarwood Oil, derived from the resinous wood of Aquilaria trees primarily found in Southeast Asia, is highly valued for its aromatic and therapeutic properties. Formed when the wood is infected by yeast, pests, or microbes, the oil possesses antimicrobial, antioxidant, anti-inflammatory making it widelyโ€ฆ

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by โ€ฆ
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emergingโ€ฆ
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio โ€ฆ
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boostโ€ฆ
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne โ€ฆ
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of theโ€ฆ
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve โ€ฆ
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:โ€ฆ
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance โ€ฆ
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launchโ€ฆ
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung โ€ฆ
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. Forโ€ฆ